Contract 36C26026F0130
Takeda Pharmaceuticals America, Inc. · Department Of Veterans Affairs · January 2, 2026
Takeda Pharmaceuticals America, Inc. was awarded a federal contract by Department Of Veterans Affairs on January 2, 2026 for an undisclosed amount of work in pharmaceutical preparation manufacturing. Performance is in Dublin, OH. This is a task or delivery order issued under parent IDIQ V797D50492. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 11, 2026.
Contract details
- PIID
- 36C26026F0130
- Parent IDIQ
- V797D50492
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Dublin, OH
- First action
- January 2, 2026
- Latest action
- June 11, 2026
Description
ADZYNMA 1500IU INJ,LYPHL.
Modification timeline
-
June 11, 2026Mod P00001 · Funding Only Action$0
-
January 2, 2026Base award$178.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26026F0130?
Contract 36C26026F0130 is a federal contract awarded to Takeda Pharmaceuticals America, Inc. by Department Of Veterans Affairs on January 2, 2026 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36C26026F0130?
Takeda Pharmaceuticals America, Inc. won contract 36C26026F0130 from Department Of Veterans Affairs.
How much is contract 36C26026F0130 worth?
Contract 36C26026F0130 has no obligated funds in the available record. It may be a pre-award placeholder or an indefinite-delivery vehicle awaiting task orders.